Analyst Ratings For NASDAQ:SURF – Surface Oncology (NASDAQ:SURF)
Today, Goldman Sachs initiated coverage on NASDAQ:SURF – Surface Oncology (NASDAQ:SURF) with a Neutral.
Some recent analyst ratings include
- 5/14/2018-Goldman Sachs initiated coverage with a Neutral rating.
- 5/14/2018-Cowen initiated coverage with a Outperform rating.
- 5/14/2018-Evercore ISI initiated coverage with a Outperform rating.
Recent Trading Activity for NASDAQ:SURF – Surface Oncology (NASDAQ:SURF)
Shares of NASDAQ:SURF – Surface Oncology closed the previous trading session at 13.79 down -0.26 1.85% with 14.055000305175781 shares trading hands.